Medical System Network Co., Ltd. (TYO:4350)
Japan · Delayed Price · Currency is JPY 502.00
+14.00 (2.87%)
Sep 11, 2026, 3:25 PM JST
Medical System Network Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 14,673 | 15,783 | 11,487 | 19,437 | 12,071 | 16,508 | |
Market Cap Growth | 2.24% | 37.40% | -40.90% | 61.02% | -26.87% | -23.53% |
Enterprise Value | 38,037 | 40,219 | 27,073 | 34,609 | 30,485 | 36,933 |
Last Close Price | 502.00 | 540.00 | 383.89 | 631.53 | 370.96 | 492.08 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.90 | 14.75 | 9.10 | 10.45 | 7.50 | 6.90 |
Forward PE | - | 5.04 | 5.04 | 9.14 | 8.33 | 6.92 |
PS Ratio | 0.11 | 0.12 | 0.09 | 0.17 | 0.11 | 0.16 |
PB Ratio | 0.86 | 0.91 | 0.70 | 1.28 | 0.83 | 1.24 |
P/TBV Ratio | 1.96 | 2.03 | 1.81 | 5.00 | 4.57 | 32.88 |
P/FCF Ratio | - | - | 6.56 | 3.32 | 3.35 | 7.95 |
P/OCF Ratio | - | - | 2.58 | 2.52 | 2.43 | 4.12 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.28 | 0.30 | 0.22 | 0.30 | 0.28 | 0.35 |
EV/EBITDA Ratio | 6.01 | 5.98 | 4.12 | 4.95 | 4.98 | 5.51 |
EV/EBIT Ratio | 13.09 | 12.14 | 8.58 | 9.03 | 9.64 | 9.59 |
EV/FCF Ratio | - | - | 15.46 | 5.90 | 8.47 | 17.79 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.78 | 2.16 | 1.82 | 1.92 | 2.11 | 2.23 |
Debt / EBITDA Ratio | - | 5.60 | 4.54 | 4.17 | 4.99 | 4.41 |
Debt / FCF Ratio | - | - | 17.01 | 4.98 | 8.48 | 14.24 |
Net Debt / Equity Ratio | 1.36 | 1.72 | 1.31 | 1.37 | 1.54 | 1.61 |
Net Debt / EBITDA Ratio | 3.62 | 4.45 | 3.25 | 2.99 | 3.66 | 3.19 |
Net Debt / FCF Ratio | - | -5.05 | 12.18 | 3.57 | 6.22 | 10.29 |
Asset Turnover | - | 1.75 | 1.76 | 1.72 | 1.70 | 1.68 |
Inventory Turnover | - | 11.45 | 12.17 | 12.50 | 12.59 | 13.33 |
Quick Ratio | 0.59 | 0.66 | 0.62 | 0.60 | 0.61 | 0.61 |
Current Ratio | 0.87 | 0.92 | 0.93 | 0.90 | 0.95 | 0.92 |
Return on Equity (ROE) | - | 6.59% | 8.23% | 12.59% | 11.73% | 19.52% |
Return on Assets (ROA) | - | 2.75% | 2.84% | 3.57% | 3.06% | 3.78% |
Return on Invested Capital (ROIC) | 6.84% | 3.40% | 4.08% | 5.70% | 4.78% | 6.72% |
Return on Capital Employed (ROCE) | 6.80% | 7.30% | 6.80% | 8.50% | 7.10% | 9.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.92% | 6.78% | 10.99% | 9.57% | 13.34% | 14.50% |
FCF Yield | -40.42% | -37.58% | 15.24% | 30.16% | 29.82% | 12.58% |
Dividend Yield | 2.39% | 2.22% | 3.13% | 1.90% | 3.23% | 2.23% |
Payout Ratio | 40.41% | 33.27% | 28.13% | 19.62% | 24.53% | 12.70% |
Buyback Yield / Dilution | - | 0.00% | 2.80% | 0.36% | -0.03% | 0.47% |
Total Shareholder Return | 2.39% | 2.22% | 5.92% | 2.26% | 3.21% | 2.71% |